Member Info for Ollieh

Https://finance.yahoo.com/news/summit-therapeutics-announces-clinical-trial-111500403.html

Chris, this is all about fda now for me .

To make the bigger gains fda approval is critical and then on to market and potential more western partnership deals for our drug.

I'm holding for sales.

So summit management ectopic put in $272 million, the rest were akeso and other pharma investors. So 26.68 million extra shares for a 500 million investment, not a bad price for future stability.

On we go.

As I said a while ago a money raising was next to come.

https://finance.yahoo.com/news/summit-therapeutics-raises-500-million-120000874.html

Needs full fda approval to keep traction now.

A way off I'd say without more long-term positive data.

Probably make its way back to the 20ts in the short term anyway.

Went to 18% up then back to 8%

Very odd with no news.

15 billion deal won't go through now I'd say, unless at a much lower cost.

Money raising is the next issue.

'The study results, reported on Sunday, showed that the drug, ivonescimab, had stronger benefit in patients with non-small cell lung cancer (NSCLC) in China, compared to patients in North America and Europe.'

Let's hope the fda are in a good mood .

May need longer-term dadt too now.

Overreacting hopefully

Markets not sure yet.

Let's see where the week finishes.

Https://www.businesswire.com/news/home/20250907860109/en/Longer-Term-Follow-Up-of-Western-Patients-Showed-Improving-Favorable-Trend-in-Overall-Survival-in-Global-Phase-III-HARMONi-Clinical-Trial-for-Ivonescimab-Plus-Chemotherapy-in-2L-EGFRm-NSCLC

Looking good for tomorrow 👍

Https://finance.yahoo.com/news/h-c-wainwright-lifts-pt-041031446.html

$50 shsre price target is not bad if it gets there.

One for holding for sure.

Https://finance.yahoo.com/news/ivonescimab-data-global-phase-iii-110000374.html

'Summit Therapeutics is reportedly in advanced talks with AstraZeneca regarding a potential $15 billion licensing deal for its lung cancer drug, ivonescimab.'

If this gets sorted then we are away.

Https://finance.yahoo.com/news/summit-therapeutics-reports-financial-results-210300076.html

Https://finance.yahoo.com/news/summit-therapeutics-insiders-added-us-145628876.html

Https://finance.yahoo.com/news/akeso-announces-completion-first-dosing-014600919.html

Good for our future potential.

Yes EP looks like this drug hopefully will be involved in a lot of different cancer treatment..

All going well we should be able to mirror results in the future here.

It will take money and time but potential is huge hopefully all going well.

Https://finance.yahoo.com/news/akeso-announces-first-patient-enrolled-014700123.html

This can only be good for our license potential

Https://finance.yahoo.com/news/china-biotech-stunning-advance-changing-210020825.html

It helps a lot when the Government is behind reforms that speed up and help drug companies grow.